Monogram Orthopaedics (MGRM) Competitors $5.80 +0.03 (+0.52%) As of 11:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRM vs. IRMD, KMTS, EMBC, TNDM, AXGN, SIBN, BVS, AVNS, ZIMV, and KIDSShould you be buying Monogram Orthopaedics stock or one of its competitors? The main competitors of Monogram Orthopaedics include iRadimed (IRMD), Kestra Medical Technologies (KMTS), Embecta (EMBC), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Monogram Orthopaedics vs. Its Competitors iRadimed Kestra Medical Technologies Embecta Tandem Diabetes Care AxoGen SiBone Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics iRadimed (NASDAQ:IRMD) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment. Do analysts prefer IRMD or MGRM? iRadimed currently has a consensus price target of $72.00, indicating a potential upside of 1.47%. Monogram Orthopaedics has a consensus price target of $5.40, indicating a potential downside of 6.90%. Given iRadimed's higher probable upside, analysts clearly believe iRadimed is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRadimed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has more volatility and risk, IRMD or MGRM? iRadimed has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Which has better earnings & valuation, IRMD or MGRM? iRadimed has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRadimed$73.24M12.32$19.23M$1.6243.80Monogram OrthopaedicsN/AN/A-$16.33M-$0.50-11.60 Is IRMD or MGRM more profitable? iRadimed has a net margin of 26.61% compared to Monogram Orthopaedics' net margin of 0.00%. iRadimed's return on equity of 23.30% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets iRadimed26.61% 23.30% 20.62% Monogram Orthopaedics N/A -126.82%-96.87% Do institutionals and insiders believe in IRMD or MGRM? 92.3% of iRadimed shares are owned by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are owned by institutional investors. 36.8% of iRadimed shares are owned by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer IRMD or MGRM? In the previous week, iRadimed had 4 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 4 mentions for iRadimed and 0 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 1.47 beat iRadimed's score of 1.39 indicating that Monogram Orthopaedics is being referred to more favorably in the news media. Company Overall Sentiment iRadimed Positive Monogram Orthopaedics Positive SummaryiRadimed beats Monogram Orthopaedics on 12 of the 15 factors compared between the two stocks. Get Monogram Orthopaedics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRM vs. The Competition Export to ExcelMetricMonogram OrthopaedicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$235.26M$6.68B$5.75B$10.37BDividend YieldN/A1.14%5.86%4.62%P/E Ratio-11.5826.7076.7526.87Price / SalesN/A193.49448.8790.16Price / CashN/A21.7137.2260.63Price / Book13.814.9614.106.37Net Income-$16.33M$178.07M$3.29B$271.28M7 Day Performance1.22%3.87%0.21%1.71%1 Month Performance9.02%6.78%4.90%7.35%1 Year Performance79.01%18.18%88.15%30.23% Monogram Orthopaedics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRMMonogram Orthopaedics1.6692 of 5 stars$5.80+0.5%$5.40-6.9%+78.6%$235.26MN/A-11.5828News CoveragePositive NewsShort Interest ↓IRMDiRadimed4.8457 of 5 stars$72.17+0.4%$72.00-0.2%+45.5%$917.94M$73.24M44.55110Positive NewsShort Interest ↓KMTSKestra Medical Technologies1.1701 of 5 stars$17.65-1.2%$27.33+54.9%N/A$906.33M$59.81M0.00300News CoveragePositive NewsEMBCEmbecta4.4446 of 5 stars$14.69+0.2%$19.00+29.4%-8.7%$854.71M$1.12B10.222,100Positive NewsTNDMTandem Diabetes Care4.2758 of 5 stars$12.58+0.6%$22.44+78.4%-71.7%$848.68M$940.20M-4.062,650Positive NewsAXGNAxoGen2.8967 of 5 stars$16.02-0.1%$26.00+62.3%+14.5%$740.07M$187.34M-160.83450SIBNSiBone3.8208 of 5 stars$16.25+0.7%$23.67+45.7%-6.2%$700.81M$167.18M-29.01350Positive NewsBVSBioventusN/A$7.19-0.3%N/AN/A$594.46M$564.14M14.201,200AVNSAVANOS MEDICAL2.2681 of 5 stars$12.48+0.4%N/A-51.0%$580.46M$687.80M-1.242,227ZIMVZimVie1.1995 of 5 stars$18.91+0.1%$17.75-6.1%+11.7%$533.31M$449.75M-27.011,770Positive NewsKIDSOrthoPediatrics4.4465 of 5 stars$20.88-0.1%$34.14+63.5%-38.1%$523.46M$204.73M-11.66200 Related Companies and Tools Related Companies iRadimed Competitors Kestra Medical Technologies Competitors Embecta Competitors Tandem Diabetes Care Competitors AxoGen Competitors SiBone Competitors Bioventus Competitors AVANOS MEDICAL Competitors ZimVie Competitors OrthoPediatrics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRM) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
